复发甲亢术中显露喉返神经的临床意义

Clinical Significance of Exposure of Recurrent Laryngeal Nerve During Surgery of Recurrent Hyperthyroidism

目的研究分析复发甲亢术中喉返神经显露的临床意义。方法选取2007年1月1日至2012年12月31日在我院行复发甲亢术的23例患者为研究对象,根据术中是否显露喉返神经进行分组,其中13例显露喉返神经的患者为治疗组,10例非显露喉返神经的患者为对照组。观察并比较两组患者的喉返神经的损伤率,手术时间和术中出血量,以及术后并发症发生率。结果治疗组喉返神经的损伤率为15.38%,显著低于对照组的50.00%,组间差异具有统计学意义(P<0.05)。治疗组的手术时间和术中出血量均显著少于对照组,组间差异具有统计学意义(P<0.05)。治疗组术后并发症发生率为23.08%,显著低于对照组的50.00%,组间差异具有统计学意义(P<0.05)。结论喉返神经显露可降低复发甲亢术患者喉返神经的损伤率,减少手术时间和术中出血量,避免患者术后并发症的发生,有利于患者的治疗和康复,值得在临床推广应用。

Objective To explore the clinical significance of exposure of recurrent laryngeal nerve during surgery of recurrent hyperthyroidism. Methods Twenty-three patients with surgery of recurrent hyperthyroidism in our hospital from January 1, 2007 to December 31, 2012 were selected as the research objects and divided into two groups, in which 13 patients with exposure of recurrent laryngeal nerve during surgery were set as the treatment group, while 10 patients without exposure of recurrent laryngeal nerve during surgery were set as the control group. The damage rate of recurrent laryngeal nerve, operating time, intraoperative blood loss, and incidence of postoperative complications were observed and compared between the two groups. Results The damage rate of recurrent laryngeal nerve was 15.38% of the treatment group, significantly lower than 50.00% of the control group （P 〈0.05）. The operating time and intraoperative blood loss of the treatment group were significantly lower than those of the control group （P 〈0.05）. The incidence of postoperative complications of the treatment group was 23.08%, significantly lower than 50.00% of the control group （P 〈0.05）. Conclusions The exposure of recurrent laryngeal nerve during surgery of recurrent hyperthyroidism can reduce the damage rate of recurrent laryngeal nerve, reduce the operating time and intraoperative blood loss, and reduce the incidence of postoperative complications, which is conducive to patients＇ treatment and rehabilitation, and is worthy of clinical application.